McMillan Office’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
Other funds holding ABT
McMillan Office's ABT Position: Q2 2026 in Review
McMillan Office reduced its Abbott (ABT) stake by 0.82% in Q2 2026, selling an estimated $36.5K and leaving 48,381 shares worth $4.39M. The position accounts for 0.5% of the portfolio, ranked #30.
McMillan Office first reported a position in ABT in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.11M in Q4 2025. 2,961 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- McMillan Office held 48,381 shares of Abbott worth $4.39M as of Q2 2026.
- McMillan Office sold 400 Abbott shares in Q2 2026, an estimated $36.5K.
- Abbott made up 0.5% of McMillan Office's portfolio in Q2 2026, its #30 holding.
- McMillan Office first reported a position in Abbott in Q4 2025 and has held it in 3 quarters since.
- McMillan Office's Abbott position peaked at $6.11M in Q4 2025.
- 2,961 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.